LifeVantage (NASDAQ:LFVN) Stock Price Down 1% – Here’s Why

Shares of LifeVantage Co. (NASDAQ:LFVN) fell 1% on Thursday . The company traded as low as $14.51 and last traded at $15.10. 42,697 shares traded hands during trading, a decline of 33% from the average session volume of 63,692 shares. The stock had previously closed at $15.25.

LifeVantage Trading Up 6.2 %

The company’s 50-day moving average is $13.42 and its 200 day moving average is $9.94. The stock has a market capitalization of $200.82 million, a PE ratio of 50.13 and a beta of 0.87.

LifeVantage (NASDAQ:LFVN) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%. The firm had revenue of $47.21 million for the quarter.

LifeVantage Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be given a $0.04 dividend. The ex-dividend date is Monday, December 2nd. This represents a $0.16 dividend on an annualized basis and a yield of 1.00%. LifeVantage’s dividend payout ratio is currently 50.00%.

Institutional Trading of LifeVantage

Institutional investors and hedge funds have recently bought and sold shares of the business. Ritholtz Wealth Management raised its holdings in shares of LifeVantage by 62.0% during the third quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock worth $346,000 after purchasing an additional 10,974 shares during the last quarter. Barclays PLC raised its holdings in LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company’s stock worth $507,000 after purchasing an additional 11,608 shares during the period. Vanguard Group Inc. raised its stake in shares of LifeVantage by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock worth $2,874,000 after buying an additional 12,809 shares during the period. Hantz Financial Services Inc. purchased a new position in LifeVantage during the second quarter valued at $91,000. Finally, Renaissance Technologies LLC lifted its stake in LifeVantage by 2.1% in the 2nd quarter. Renaissance Technologies LLC now owns 855,118 shares of the company’s stock valued at $5,490,000 after buying an additional 17,300 shares in the last quarter. 35.32% of the stock is currently owned by institutional investors and hedge funds.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.